最新报道:ProPhase Labs, a diversified diagnostics and genomics company, has announced a significant Bitcoin purchase as part of its strategic diversification plan. The firm acquired an undisclosed amount of Bitcoin, citing its long-term potential as a store of value and hedge against inflation. CEO Ted Karkus emphasized the move aligns with the company's commitment to innovation and forward-thinking investments. This purchase marks ProPhase Labs' entry into digital assets, joining a growing list of public companies adding Bitcoin to their balance sheets. The company plans to hold the Bitcoin as a treasury asset while continuing to explore blockchain-related opportunities.